Inventor · disambiguated record
Tomoko Terauchi
Also filed as: TERAUCHI TOMOKO
7 granted patents·3 pending applications·12 citations·filing 2018–2024
78Inventor score
Top patents by PatentIndex Score
10 records- 0196US10906974B2Anti-GPR20 antibody and anti-GPR20 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2020·Granted Feb 2, 2021·9 cites·30 claims
- 0290US12246196B2Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diazepinesDAIICHI SANKYO CO LTD·Filed 2022·Granted Mar 11, 2025·1 cites·34 claims
- 0389US11583590B2Antibody-pyrrolobenzodiazepine derivative conjugate and method of use thereof for treating a tumorDAIICHI SANKYO CO LTD·Filed 2021·Granted Feb 21, 2023·1 cites·30 claims
- 0484US2025114647A1ANTIBODY-DRUG CONJUGATES COMPRISING SUBSTITUTED BENZO[e]PYRROLO[1,2-a][1,4]DIAZEPINESDAIICHI SANKYO COMPANY LIMTED·Filed 2024·Application pending·0 cites
- 0583US11628223B2Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-α][1,4]diazepinesDAIICHI SANKYO CO LTD·Filed 2018·Granted Apr 18, 2023·1 cites·1 claims
- 0678US12350344B2Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugateDAIICHI SANKYO CO LTD·Filed 2022·Granted Jul 8, 2025·0 cites·36 claims
- 0765US12138315B2Anti-CD37 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2024·Granted Nov 12, 2024·0 cites·46 claims
- 0861US2025025571A1Anti-cd37 antibody-drug conjugateDAIICHI SAMKO COMPANY LTD·Filed 2024·Application pending·0 cites
- 0958US2025034274A1Protease-cleavable masked antibodiesDAIICHI SANKYO CO LTD·Filed 2022·Application pending·0 cites
- 1056US11434289B2Anti-GPR20 antibody and anti-GPR20 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2018·Granted Sep 6, 2022·0 cites·44 claims
Join the waitlist — get patent alerts
Get an alert when Tomoko Terauchi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →